Dendritic Cell Based PSMA Immunotherapy for Prostate Cancer Using a CD40-Targeted Adenovirus Vector

Human prostate tumor vaccine and gene therapy trials using ex vivo methods to prime dendritic cells (DCs) with prostate specific membrane antigen (PSMA) have been somewhat successful, but to date the lengthy ex vivo manipulation of DCs has limited the widespread clinical utility of this approach. Ou...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Williams, Briana Jill, Bhatia, Shilpa, Adams, Lisa K., Boling, Susan, Carroll, Jennifer L., Li, Xiao-Lin, Rogers, Donna L., Korokhov, Nikolay, Kovesdi, Imre, Pereboev, Alexander V., Curiel, David T., Mathis, J. Michael
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2012
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3466199/
https://ncbi.nlm.nih.gov/pubmed/23056548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0046981
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы